CA2164837A1 - Compositions therapeutiques et methodes d'utilisation - Google Patents

Compositions therapeutiques et methodes d'utilisation

Info

Publication number
CA2164837A1
CA2164837A1 CA 2164837 CA2164837A CA2164837A1 CA 2164837 A1 CA2164837 A1 CA 2164837A1 CA 2164837 CA2164837 CA 2164837 CA 2164837 A CA2164837 A CA 2164837A CA 2164837 A1 CA2164837 A1 CA 2164837A1
Authority
CA
Canada
Prior art keywords
weight
parts
acid
component
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2164837
Other languages
English (en)
Inventor
Raymond K. Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2164837A1 publication Critical patent/CA2164837A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne un mélange d'acide sorbique, d'acide malique, d'acide fumarique, d'acide crotonique et, éventuellement, d'acide aconitique. La présente invention concerne également des procédés pour le traitement de divers états pathologiques, tels que les infections virales, l'acidose, les tumeurs et les infections bactériennes et fongiques par administration de quantités thérapeutiquement efficaces d'un mélange décrit ci-dessus.
CA 2164837 1993-06-08 1994-06-08 Compositions therapeutiques et methodes d'utilisation Abandoned CA2164837A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7393493A 1993-06-08 1993-06-08
US073,934 1993-06-08

Publications (1)

Publication Number Publication Date
CA2164837A1 true CA2164837A1 (fr) 1994-12-22

Family

ID=22116689

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2164837 Abandoned CA2164837A1 (fr) 1993-06-08 1994-06-08 Compositions therapeutiques et methodes d'utilisation

Country Status (5)

Country Link
AU (1) AU7060394A (fr)
CA (1) CA2164837A1 (fr)
DE (1) DE4494231T1 (fr)
GB (1) GB2294637B (fr)
WO (1) WO1994028883A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1785799A (en) * 1998-01-30 1999-08-16 Ivan Gorgiev Anticancer composition
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
AUPP839499A0 (en) 1999-01-29 1999-02-25 Australian National University, The A method for controlling plant pathogens, and agents useful for same
ATE447945T1 (de) 2001-01-12 2009-11-15 Biogen Idec Internat Gmbh Verwendung von fumarsäureamiden
DE10101307A1 (de) * 2001-01-12 2002-08-01 Fumapharm Ag Muri Fumarsäurederivate als NF-kappaB-Inhibitor
DE10217314A1 (de) 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
SI1663197T1 (sl) 2003-09-09 2008-06-30 Biogen Idec Internat Gmbh Uporaba derivatov fumarne kisline za zdravljenje sräśne insuficience in astme
ES2916604T1 (es) 2007-02-08 2022-07-04 Biogen Ma Inc Ensayos de detección de nrf2 y métodos y composiciones relacionados
WO2024126742A1 (fr) * 2022-12-16 2024-06-20 Universite De Tours Aconitate pour traitement d'une infection pulmonaire virale

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828912A (en) * 1981-07-20 1989-05-09 Kimberly-Clark Corporation Virucidal product having virucidal and/or germicidal properties

Also Published As

Publication number Publication date
DE4494231T1 (de) 1996-10-17
GB2294637A (en) 1996-05-08
GB9525254D0 (en) 1996-02-21
AU7060394A (en) 1995-01-03
WO1994028883A1 (fr) 1994-12-22
GB2294637B (en) 1997-11-12

Similar Documents

Publication Publication Date Title
JANDL et al. The metabolism of folic acid in cirrhosis
Polak et al. Mode of action of the 2-nitroimidazole derivative benznidazole
US6180139B1 (en) Composition and method for treating nonalcoholic steatohepatitis
US5684045A (en) Method of treating pancreatic atrophy
US5397803A (en) Use of glutamine to reduce rate of pathogenic microorganism infection
Ershoff Conditioning factors in nutritional disease
AU758264B2 (en) Inorganic nitrite and organic acid in combination as topical antiviral composition
KR20070048170A (ko) 젖산 및 락토페린을 포함하는 조성물
KR20070092095A (ko) 소독용 조성물 및 이의 제조 및 이용 방법
JP2002515410A (ja) 広域スペクトルの殺菌用及び殺精子用の組成物、装置、及び方法
CA2164837A1 (fr) Compositions therapeutiques et methodes d'utilisation
US6066670A (en) Therapeutic compositions and methods of use
De Koning et al. Combination therapy for dendritic keratitis with human leucocyte interferon and trifluorothymidine.
Monafo et al. 'Lethal'Burns: A Progress Report
Drummond et al. Suppression of hyperbilirubinemia in the rat neonate by chromium-protoporphyrin. Interactions of metalloporphyrins with microsomal heme oxygenase of human spleen.
Lane et al. The rapid induction of human riboflavin deficiency with galactoflavin
Victor et al. Pyomyositis in a patient with the acquired immunodeficiency syndrome
HU220214B (hu) Eljárás patológiás bél-permeabilitás és legyengült immunfunkciók kezelésére alkalmas, glutamintartalmú gyógyszerkészítmények előállítására
JP2001503067A (ja) チゾキサニドおよびニタゾキサニドの薬剤の合成物
AU7943794A (en) Flavin derivatives as anti-viral agents
WO1995035103A1 (fr) Composition pharmaceutique pour prevenir et/ou traiter des infections virales, ainsi qu'eventuellement des inflammations, et utilisation de cette composition
US5869446A (en) Preparation of lactoferrin (or serotransferrin or ovotransferrin) and desferrioxamine methanesulfonate (or other low molecular weight metal ion chelators) for the therapy of viral infections
JPS63501422A (ja) 生殖器及び口腔ヘルペスの治療方法
SU1722502A1 (ru) Препарат биоспорин дл профилактики и лечени желудочно-кишечных заболеваний человека
AU640223B2 (en) Supportive use

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead